Get the latest news, insights, and market updates on ADNT (Adient plc). Explore the news page 3 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.
Adient (ADNT) Valuation Check After Mixed Short And Long Term Share Price Performance
Adient (ADNT) has been drawing attention after a stretch of mixed share performance, combining a one-month gain with a decline over the past three months, alongside improving annual revenue and net income figures on a reported basis. See our latest analysis for Adient. At a recent share price of $20.60, Adient has paired a 9.52% 30 day share price return with an 8.19% year to date gain. This contrasts with a 90 day share price decline of 8.57% and a 3 year total shareholder return loss of... Jan 11, 2026 - $ADNT
Is Adient (ADNT) Stock Undervalued Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. Jan 6, 2026 - $ADNT
Adient Formed a Joint Venture with SCI to Drive Growth in China
Recently, Adient, a global leader in automotive seating, completed the acquisition of a 49% equity stake in SCI (Zhangjiakou) Co., Ltd., a local Chinese supplier under Zhejiang Yoening Technology Group, officially establishing a new strategic joint venture. This joint venture will be dedicated to developing and manufacturing innovative and exceptional automotive seating solutions for the rapidly evolving China market, with a particular focus on serving key Chinese OEMs. Dec 8, 2025 - $ADNT
We use cookies and similar technologies to collect and process data such as browsing activity or unique identifiers.
Selecting "Allow All" to help us understand site usage and improve the platform.
Choosing "Essential Cookies Only" enables only the cookies necessary for core site functions, such as staying logged in.
For more information, please see our Privacy Policy.